SPR-206
N/A
Report date: 2025/04/29 15:22:35
NMEQIDP
Base Information
Drug NameSPR-206
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[7]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[5]
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNorthern Antibiotics
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesEverest Medicines LtdHealthCare Royalty Management LLCPfizer Inc +[4]
Inactive CompaniesN/A
Active Indications +[7]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A